EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protection and Repair of the Nigrostriatal Pathway with Stem-Cell-Derived Carotid Body Glomus Cell Transplants in Chronic MPTP Parkinsonian Model

Javier Villadiego iD, Ana B Muñoz-Manchado, Verónica Sobrino, Victoria Bonilla-Henao iD, Nela Suárez-Luna, Patricia Ortega-Sáenz, Ricardo Pardal iD, José López-Barneo, Juan J Toledo-Aral

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Javier Villadiego und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain. Hauptthemen laut MEDLINE: Carotid Body, Parkinson Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCIN/Spanish Research Agency (AEI), Red TerCel ISCIII, Consejería de Economía, Conocimiento, Empresas y Universidad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiparkinsonian carotid body (CB) cell therapy has been proven to be effective in rodent and nonhuman primate models of Parkinson’s disease (PD), exerting trophic protection and restoration of the dopaminergic nigrostriatal pathway. These neurotrophic actions are mediated through the release of high levels of glial-cell-line-derived neurotrophic factor (GDNF) by the CB transplant. Pilot clinical trials have also shown that CB autotransplantation can improve motor symptoms in PD patients, although its effectiveness is affected by the scarcity of the grafted tissue. Here, we analyzed the antiparkinsonian efficacy of in vitro-expanded CB dopaminergic glomus cells. Intrastriatal xenografts of rat CB neurospheres were shown to protect nigral neurons from degeneration in a chronic MPTP mouse PD model. In addition, grafts performed at the end of the neurotoxic treatment resulted in the repair of striatal dopaminergic terminals through axonal sprouting. Interestingly, both neuroprotective and reparative effects induced by in vitro-expanded CB cells were similar to those previously reported by the use of CB transplants. This action could be explained because stem-cell-derived CB neurospheres produce similar amounts of GDNF compared to native CB tissue. This study provides the first evidence that in vitro-expanded CB cells could be a clinical option for cell therapy in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carotid BodyParkinson DiseaseMiceRatsHumansAnimalsGlial Cell Line-Derived Neurotrophic FactorDopamineDopaminergic NeuronsCell TransplantationSubstantia NigraDisease Models, AnimalCorpus Striatum

Stichwörter der Autor:innen

Parkinson’s diseasecarotid body stem cellscell therapyneuroprotectionneurorestoration

Substanzen

Glial Cell Line-Derived Neurotrophic FactorDopamine

Autor:innen und Institutionen

  • Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
  • Departamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain.
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28029 Madrid, Spain.
  • Unidad de Biología Celular, Departamento de Anatomía Patológica, Biología Celular, Histología, Historia de la Ciencia, Medicina Legal y Forense y Toxicología, INiBICA (Instituto de Investigación e Innovación Biomédica d…
  • Instituto Maimónides de Investigación Biomédica de Córdoba, Departamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, 14004 Córdoba, Spain.

ORCID-Profile: Javier Villadiego, Victoria Bonilla-Henao, Ricardo Pardal

Förderung

  • MCIN/Spanish Research Agency (AEI)
  • Red TerCel ISCIII
  • Consejería de Economía, Conocimiento, Empresas y Universidad

Zitieren

APA

Villadiego, J., Muñoz-Manchado, A. B., Sobrino, V., Bonilla-Henao, V., Suárez-Luna, N., Ortega-Sáenz, P., Pardal, R., López-Barneo, J., & Toledo-Aral, J. J. (2023). Protection and Repair of the Nigrostriatal Pathway with Stem-Cell-Derived Carotid Body Glomus Cell Transplants in Chronic MPTP Parkinsonian Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065575

Vancouver

Villadiego J, Muñoz-Manchado AB, Sobrino V, Bonilla-Henao V, Suárez-Luna N, Ortega-Sáenz P, et al. Protection and Repair of the Nigrostriatal Pathway with Stem-Cell-Derived Carotid Body Glomus Cell Transplants in Chronic MPTP Parkinsonian Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065575

BibTeX
@article{Villadiego2023,
  author = {Villadiego, Javier and Muñoz-Manchado, Ana B and Sobrino, Verónica and Bonilla-Henao, Victoria and Suárez-Luna, Nela and Ortega-Sáenz, Patricia and Pardal, Ricardo and López-Barneo, José and Toledo-Aral, Juan J},
  title = {Protection and Repair of the Nigrostriatal Pathway with Stem-Cell-Derived Carotid Body Glomus Cell Transplants in Chronic MPTP Parkinsonian Model},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065575}
}
Kostenlos starten →